CannLabs, Inc. (CANL) Research

Headquartered in Denver, Colorado, CannLabs, Inc. is a leading provider of cannabis testing laboratory services throughout the United States. The company offers an extensive suite of analytical tests, including assessments for potency, residual solvents, microbiological contaminants, pesticides, heavy metals, nutrients, and terpenes. They also conduct shelf-life and stability studies, alongside gene expression and genetic profiling (genotyping/phenotyping). In addition to their laboratory work, CannLabs provides data and analytics solutions, consulting expertise, and educational services.

Market snapshot

Symbol
CANL
Price
$0.00
Day change
0.00%
Market cap
$93.3K
P/E ratio
0.09x
52-week range
0.0001-0.01
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Advantis Corp. (ADVT)
  • Black Bird Biotech, Inc. (BBBT)
  • Parallel Industries Inc. (EAPH)
  • The Greater Cannabis Company, Inc. (GCAN)
  • Green Rain Energy Holdings Inc. (GREH)
  • Item 9 Labs Corp. (INLB)
  • Street Capital Inc. (REZNF)
  • Transnational Cannabis Ltd. (TRCNF)

Open CannLabs, Inc. (CANL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.